Skip to main content
Retour
Watch Compare

CTT PHARMACEUTICAL HOLDINGS, INC.

Qualité des données : 83%
CTTH
OTC Energy Metal Mining
0,07 €
▼ 0,00 € (-2,84%)
Cap. Boursière: 3,82 M
Prix
0,07 €
Cap. Boursière
3,82 M
Fourchette du Jour
0,07 € — 0,07 €
Fourchette 52 Semaines
0,02 € — 0,10 €
Volume
11 741
Ouverture 0,07 €
Moyenne 50J / 200J
0,08 €
18,85% below
Moyenne 50J / 200J
0,06 €
10,92% above

Quick Summary

Points Clés

Earnings grew 106,26% over the past year
Negative free cash flow of -131 174,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)106,26%
FCF Growth (3Y)N/A

Qualité

Return on Equity
-89,30%
En dessous de la moyenne du secteur (3,47%)
ROIC-72,02%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valorisation

PE (TTM)
-4,97
En dessous de la moyenne du secteur (3,38)
P/B Ratio5,18
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Energy (539 pairs)
Métrique Action Médiane du Secteur
P/E -5,0 3,4
P/B 5,2 2,1
ROE % -89,3 3,5
Net Margin % — 4,9
Rev Growth 5Y % — 9,3
D/E — 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) 106,26% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -770 159,0
ROE -89,30% ROA -73,16%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -131 174,0
ROIC -72,02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value 738 078
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,97 Forward P/E N/A
P/B Ratio 5,18 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3,43%
Market Cap 3,82 M Enterprise Value 3,79 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 17,03%
SBC-Adj. FCF -270 398 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Revenue — — — —
Net Income 227 838,0 110 464,0 -1,00 M 3,74 M
EPS (Diluted) — 0,01 -0,11 0,40
Gross Profit — — — —
Operating Income -672 162,0 92 201,0 -1,19 M -757 935,0
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — 0,0
Interest Expense — — — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2014 FY2013 FY2012 FY2011
Total Assets 1,66 M 6 252,0 203 079,0 4,18 M
Total Liabilities 1,08 M 249 378,0 589 413,0 3,73 M
Shareholders' Equity 586 630,0 -243 126,0 -386 334,0 456 450,0
Total Debt — — — —
Cash & Equivalents 81 179,0 823,0 12 091,0 569 378,0
Current Assets 1,05 M 6 252,0 203 079,0 750 734,0
Current Liabilities — 249 378,0 589 413,0 3,73 M